|
1
|
Global Burden of Disease Cancer
Collaboration, . Fitzmaurice C, Dicker D, Pain A, Hamavid H,
Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, et
al: The global burden of cancer 2013. JAMA Oncol. 1:505–527. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen WQ and Zheng RS: Incidence, mortality
and survival analysis of breast cancer in China. Chin J Clin Oncol.
42:668–674. 2015.
|
|
4
|
Fan L, Strasser-Weippl K, Li JJ, St Louis
J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM and Goss PE: Breast
cancer in China. Lancet Oncol. 15:e279–e289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tatsumoto T, Xie X, Blumenthal R, Okamoto
I and Miki T: Human ECT2 is an exchange factor for Rho GTPases,
phosphorylated in G2/M phases, and involved in cytokinesis. J Cell
Biol. 147:921–928. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fields AP and Justilien V: The guanine
nucleotide exchange factor (GEF) Ect2 is an oncogene in human
cancer. Adv Enzyme Regul. 50:190–200. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Justilien V and Fields AP: Ect2 links the
PKCiota-Par6alpha complex to Rac1 activation and cellular
transformation. Oncogene. 28:3597–3607. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huff LP, Decristo MJ, Trembath D, Kuan PF,
Yim M, Liu J, Cook DR, Miller CR, Der CJ and Cox AD: The role of
Ect2 nuclear RhoGEF activity in ovarian cancer cell transformation.
Genes Cancer. 4:460–475. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mansour M, Haupt S, Chan AL, Godde N,
Rizzitelli A, Loi S, Caramia F, Deb S, Takano EA, Bishton M, et al:
The E3-ligase E6AP represses breast cancer metastasis via
regulation of ECT2-Rho signaling. Cancer Res. 76:4236–4248. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jézéquel P, Frénel JS, Campion L,
Guérin-Charbonnel C, Gouraud W, Ricolleau G and Campone M:
bc-GenExMiner 3.0: New mining module computes breast cancer gene
expression correlation analyses. Database (Oxford).
2013:bas0602013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Szász AM, Lánczky A, Nagy Á, Förster S,
Hark K, Green JE, Boussioutas A, Busuttil R, Szabó A and Győrffy B:
Cross-validation of survival associated biomarkers in gastric
cancer using transcriptomic data of 1,065 patients. Oncotarget.
7:49322–49333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Miki T, Smith CL, Long JE, Eva A and
Fleming TP: Oncogene ect2 is related to regulators of small
GTP-binding proteins. Nature. 362:462–465. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang HB, Yan HC and Liu Y: Clinical
significance of ECT2 expression in tissue and serum of gastric
cancer patients. Clin Transl Oncol. 18:735–742. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Scoumanne A and Chen X: The epithelial
cell transforming sequence 2, a guanine nucleotide exchange factor
for Rho GTPases, is repressed by p53 via protein methyltransferases
and is required for G1-S transition. Cancer Res. 66:6271–6279.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Duquette PM and Lamarche-Vane N: Rho
GTPases in embryonic development. Small GTPases. 5:e9728572014.
View Article : Google Scholar
|
|
18
|
Matsuoka T and Yashiro M: Rho/ROCK
signaling in motility and metastasis of gastric cancer. World J
Gastroenterol. 20:13756–13766. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tanabe K, Shinsato Y, Furukawa T, Kita Y,
Hatanaka K, Minami K, Kawahara K, Yamamoto M, Baba K, Mori S, et
al: Filamin C promotes lymphatic invasion and lymphatic metastasis
and increases cell motility by regulating Rho GTPase in esophageal
squamous cell carcinoma. Oncotarget. 8:6353–6363. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cook DR, Rossman KL and Der CJ: Rho
guanine nucleotide exchange factors: Regulators of Rho GTPase
activity in development and disease. Oncogene. 33:4021–4035. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Luo Y, Qin SL, Mu YF, Wang ZS, Zhong M and
Bian ZQ: Elevated expression of ECT2 predicts unfavorable prognosis
in patients with colorectal cancer. Biomed Pharmacother.
73:135–139. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Justilien V, Ali SA, Jamieson L, Yin N,
Cox AD, Der CJ, Murray NR and Fields AP: Ect2-dependent rRNA
synthesis is required for KRAS-TRP53-driven lung adenocarcinoma.
Cancer Cell. 31:256–269. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo Z, Chen X, Du T, Zhu D, Lai Y, Dong W,
Wu W, Lin C, Liu L and Huang H: Elevated levels of epithelial cell
transforming sequence 2 predicts poor prognosis for prostate
cancer. Med Oncol. 34:132017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hirata D, Yamabuki T, Miki D, Ito T,
Tsuchiya E, Fujita M, Hosokawa M, Chayama K, Nakamura Y and Daigo
Y: Involvement of epithelial cell transforming sequence-2
oncoantigen in lung and esophageal cancer progression. Clin Cancer
Res. 15:256–266. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang HK, Liang JF, Zheng HX and Xiao H:
Expression and prognostic significance of ECT2 in invasive breast
cancer. J Clin Pathol. 71:442–445. 2018. View Article : Google Scholar : PubMed/NCBI
|
